Moderna and Pfizer announced they are moving forward with trials of a new booster designed to guard specifically against omicron. This comes as the CDC reported Thursday that a third shot of either of those vaccines substantially reduced the risk of hospitalizations among people with weakened immune systems. Amna Nawaz speaks with a top Moderna scientist about several key vaccine questions.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts